{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:04:25Z","timestamp":1792271065171,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0742-y","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T22:26:44Z","timestamp":1524781604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Marlene","family":"Bloechliger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Reinau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spoendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kuhlbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"742_CR1","doi-asserted-by":"publisher","unstructured":"Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. Asthma. Nat Rev Dis Prim. 2015; \n                    https:\/\/doi.org\/10.1038\/nrdp.2015.25\n                    \n                  .","DOI":"10.1038\/nrdp.2015.25"},{"key":"742_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s15006-015-2720-3","volume":"157","author":"A Gillissen","year":"2015","unstructured":"Gillissen A. Asthma bronchiale \u2013 was bleibt , was ist neu\u00a0? MMW-Fortschritt Medizin. 2015;157:55\u201362.","journal-title":"MMW-Fortschritt Medizin"},{"key":"742_CR3","volume-title":"NICE guidance asthma","author":"National Institute for Health and Care Excellence (NICE)","year":"2013","unstructured":"National Institute for Health and Care Excellence (NICE). NICE guidance asthma. 2013. \n                    https:\/\/www.nice.org.uk\/guidance\/qs25\n                    \n                  . Accessed 15 May 2017."},{"key":"742_CR4","volume-title":"GINA Report, Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2017","unstructured":"Global Initiative for Asthma. 2017 GINA Report, Global Strategy for Asthma Management and Prevention \n                    http:\/\/ginasthma.org\/2017-gina-report-global-strategy-for-asthma-management-and-prevention\n                    \n                  . Accessed 15 May 2017."},{"key":"742_CR5","unstructured":"British thoracic society. British guideline on the management of asthma. A national clinical guideline. Scottish Intercoll Guidel Netw. 2016; October:11\u201375. \n                    https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/asthma\/btssign-asthma-guideline-2016\n                    \n                  . Accessed 15 May 2017"},{"key":"742_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","volume":"20","author":"AK McDonough","year":"2008","unstructured":"McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20:131\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"742_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Care Res. 2006;55:420\u20136.","journal-title":"Arthritis Care Res"},{"key":"742_CR8","first-page":"357","volume":"j1415","author":"AK Waljee","year":"2017","unstructured":"Waljee AK, Rogers MAM, Lin P, Singal AG, Stein JD, Marks RM, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;j1415:357.","journal-title":"BMJ"},{"key":"742_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","volume":"103","author":"SC Manson","year":"2009","unstructured":"Manson SC, Brown RE, Cerulli A, Vidaurre CF. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med. 2009;103:975\u201394.","journal-title":"Respir Med"},{"key":"742_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2500\/aap.2015.36.3863","volume":"36","author":"JL Zazzali","year":"2015","unstructured":"Zazzali JL, Broder MS, Omachi TA, Chang E, Sun GH, Raimundo K. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use. Allergy Asthma Proc. 2015;36:268\u201374.","journal-title":"Allergy Asthma Proc"},{"key":"742_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thoraxjnl-2015-207630","volume":"71","author":"J Sweeney","year":"2016","unstructured":"Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the optimum patient care research database and the British thoracic difficult asthma registry. Thorax. 2016;71:339\u201346.","journal-title":"Thorax"},{"key":"742_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.18553\/jmcp.2016.22.7.833","volume":"22","author":"AA Dalal","year":"2016","unstructured":"Dalal AA, Duh MS, Gozalo L, Robitaille M-N, Albers F, Yancey S, et al. Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma. J Manag care Spec Pharm. 2016;22:833\u201347.","journal-title":"J Manag care Spec Pharm"},{"key":"742_CR13","doi-asserted-by":"crossref","unstructured":"Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136(6):1488-95.","DOI":"10.1016\/j.jaci.2015.07.046"},{"key":"742_CR14","doi-asserted-by":"publisher","unstructured":"Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthma. J Allergy Clin Immunol. 2017; \n                    https:\/\/doi.org\/10.1016\/j.jaci.2017.04.009\n                    \n                  . [Epub ahead of print].","DOI":"10.1016\/j.jaci.2017.04.009"},{"key":"742_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336.","journal-title":"Int J Epidemiol"},{"key":"742_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol. 2010;69:4\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"742_CR17","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract. 2010;60:e128\u201336.","journal-title":"Br J Gen Pract"},{"key":"742_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/qjmed\/hci029","volume":"98","author":"TP Van Staa","year":"2005","unstructured":"Van Staa TP, Geusens P, Pols HAP, De Laet C, Leufkens HGM, Cooper C. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM. 2005;98:191\u20138.","journal-title":"QJM"},{"key":"742_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-11-1","volume":"11","author":"NF Khan","year":"2010","unstructured":"Khan NF, Perera R, Harper S, Rose PW. Adaptation and validation of the Charlson index for read\/OXMIS coded databases. BMC Fam Pract. 2010;11:1.","journal-title":"BMC Fam Pract"},{"key":"742_CR20","doi-asserted-by":"crossref","unstructured":"Lam D, Rao SK, Ratra V, Liu Y, Mitchell P, King J, et al. Cataract. Nat Rev Dis Prim. 2015; \n                    http:\/\/www.nature.com\/articles\/nrdp201514\n                    \n                  . Accessed 15 May 2017.","DOI":"10.1038\/nrdp.2015.14"},{"key":"742_CR21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.clinthera.2011.09.009","volume":"33","author":"E Sarnes","year":"2011","unstructured":"Sarnes E, Crofford L, Watson M, Dennis G, Kan H, Incidence BD. US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther. 2011;33:1413\u201332.","journal-title":"Clin Ther"},{"key":"742_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40266-012-0029-9","volume":"29","author":"MW Marcus","year":"2012","unstructured":"Marcus MW, M\u00fcskens RPHM, Ramdas WD, Wolfs RCW, De Jong PTVM, Vingerling JR, et al. Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs and Aging. 2012;29:963\u201370.","journal-title":"Drugs and Aging"},{"key":"742_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/thorax.56.4.279","volume":"56","author":"LJ Walsh","year":"2001","unstructured":"Walsh LJ, Wong CA, Oborne J, Cooper S, Lewis SA, Pringle M, et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax. 2001;56:279\u201384.","journal-title":"Thorax"},{"key":"742_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68:1119\u201324.","journal-title":"Ann Rheum Dis"},{"key":"742_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1710-1492-9-1","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. Immunology a practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9:1.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"742_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MCP.0b013e32835b113a","volume":"19","author":"M Cazzola","year":"2013","unstructured":"Cazzola M, Segreti A, Calzetta L, Rogliani P. Comorbidities of asthma: current knowledge and future research needs. Curr Opin Pulm Med. 2013;19:36\u201341.","journal-title":"Curr Opin Pulm Med"},{"key":"742_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/ACI.0b013e32835c16b6","volume":"13","author":"DK Ledford","year":"2013","unstructured":"Ledford DK, Lockey RF. Asthma and comorbidities. Curr Opin Allergy Clin Immunol. 2013;13:78\u201386.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"742_CR28","doi-asserted-by":"publisher","first-page":"3690628","DOI":"10.1155\/2016\/3690628","volume":"2016","author":"H Kankaanranta","year":"2016","unstructured":"Kankaanranta H, Kauppi P, Tuomisto LE, Ilmarinen P. Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms. Mediat Inflamm. 2016;2016:3690628.","journal-title":"Mediat Inflamm"},{"key":"742_CR29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/ije\/dyn064","volume":"37","author":"S Greenland","year":"2008","unstructured":"Greenland S. Multiple comparisons and association selection in general epidemiology. Int J Epidemiol. 2008;37:430\u20134.","journal-title":"Int J Epidemiol"},{"key":"742_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/oxfordjournals.aje.a117737","volume":"142","author":"DA Savitz","year":"1995","unstructured":"Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 1995;142:904\u20138.","journal-title":"Am J Epidemiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0742-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:19:32Z","timestamp":1556306372000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0742-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0742-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"10 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Independent Scientific Advisory Committee for Medicines and Healthcare Products Regulatory Agency research (protocol number 16_060R).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB, DR, JS, SJ, and CRM have no conflicts of interest.SCC was an employee of Genentech at the timing of study conduction, a member of the F. Hoffmann-La Roche group.KK is an employee of F. Hoffmann-La Roche Ltd.LH reports grants from Genentech during the conduct of the study, and other payment for consultancy (F. Hoffmann-La Roche Ltd., Astra Zeneca, Novartis, Glaxo Smith Kline, Teva, Medimmune, Amgen, Boehringer Ingelheim, Aerocrine and Vitalograph), outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}